FDA Approves Expanded Indication for Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Advanced Melanoma News FDA Approves Expanded Indication for Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Advanced Melanoma
Cancer and the Holidays: Answers to Common Questions Blog Cancer and the Holidays: Answers to Common Questions
FDA allows marketing of cooling cap to reduce hair loss during chemotherapy News FDA allows marketing of cooling cap to reduce hair loss during chemotherapy
Important holiday safety advice for cancer patients and families Blog Important holiday safety advice for cancer patients and families
